Finance

Lists
Q3 2026 earnings • released • EPS miss -2.44%
See results
PEPG:NASDAQ
PepGen Inc
$4.36
-13.49%
(-0.68) 1D
$4.42
+1.38% (+0.060)
After hours
Closed: Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PEPG...
Open
$5.08
High
$5.08
Low
$4.34
Mkt. cap
301.98M
Avg. vol.
5.38M
Volume
5.92M
52-wk high
$7.80
52-wk low
$1.31
EPS
-$1.06
Beta
2.02
Shares outstanding
69.26M
No. of employees
57
Open
$5.08
High
$5.08
Low
$4.34
Mkt. cap
301.98M
Avg. vol.
5.38M
Volume
5.92M
52-wk high
$7.80
52-wk low
$1.31
EPS
-$1.06
Beta
2.02
Shares outstanding
69.26M
No. of employees
57
News stories
From web sources and news partners
About PepGen Inc
CEO-
Employees57
Founded2018
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepepgen.com
Analyst ratings
Based on 7 analysts giving stock ratings to PEPG in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PEPG in the last 3 months.
Highest
Current $4.36
$20.00 (+358.72%)
Average
$14.29 (+227.75%)
Lowest
$6.00 (+37.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debjit Chattopadhyay
Guggenheim
Buy
Reiterated
$15.00
+244%
11/12/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
$16.00
+267%
11/11/2026
Joseph Schwartz
Leerink Partners
Buy
Maintained
$16.00
+267%
11/10/2026
Tazeen Ahmad
Bank of America Securities
Hold
Upgraded
$6.00
+37.6%
11/10/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$12.00
+175.2%
11/10/2026
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
$20.00
+358.7%
11/10/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$15.00
+244%
10/07/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$10.00
+129.4%
09/18/2026
Laura Chico
Wedbush
Buy
Maintained
$4.00
-8.3%
05/13/2026
Unknown Analyst
Wedbush
Buy
Maintained
$9.00
+106.4%
03/23/2026
Last report
Nov 10, 2026
Fiscal period
Q3 2026
-$0.28 / -$0.27
-2.44%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13.85M
13.00M
12.52M
14.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.85M
5.94M
6.42M
5.91M
Operating expense
19.70M
18.94M
18.94M
20.38M
Total operating expenses
19.70M
18.94M
18.94M
20.38M
Operating income
-19.70M
-18.94M
-18.94M
-20.38M
Other non operating income
-5.00K
-56.00K
50.00K
-
EBT including unusual items
-18.29M
-17.75M
-17.80M
-19.38M
EBT excluding unusual items
-18.29M
-17.75M
-17.80M
-19.38M
Income tax expense
49.00K
15.00K
16.00K
13.00K
Effective tax rate
-0.27%
-0.08%
-0.09%
-0.07%
Other operating expenses
-
-
-
-
Net income
-18.34M
-17.76M
-17.81M
-19.39M
Net profit margin
-
-
-
-
Earnings per share
-0.27
-0.26
-0.26
-0.28
Interest and investment income
1.42M
1.25M
1.09M
1.00M
Interest expense
-
-
-
-
Net interest expenses
1.42M
1.25M
1.09M
1.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.37M
-18.62M
-18.69M
-20.14M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps